person · Reporting owner
Westfall Nicholas Michael
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CHEMED CORP
Report date February 05, 2026 · Filed February 05, 2026
Section 16 reporting ended · disclosed 2026-02-05. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2018 Filed Dec 12, 2018 20:04 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 12,000 | $135.85 | $1,630,200.00 |
DisclosureSEC source: 0001209191-18-062206 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 20:04 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,709 | $301.75 | $1,722,690.75 |
DisclosureSEC source: 0001209191-18-062206 · doc4.xml · nonDerivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,343 Read SEC document |
| December 10, 2018 Filed Jan 30, 2019 18:26 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 12,291 | $302.47 | $3,717,658.77 |
DisclosureSEC source: 0001209191-19-005979 · doc4a.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,052 Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:41 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 13,500 | $306.70 Strike: $306.70 | $4,140,450.00 |
DisclosureSEC source: 0001209191-18-057078 · doc4.xml · derivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,100 Underlying: capital stock · 13,500 shares Expires 2023-11-02 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| May 22, 2018 Filed May 22, 2018 14:35 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 220 | $333.53 | $73,376.60 |
DisclosureSEC source: 0001209191-18-032193 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,052 F1 · kind: stock award tax obligation Read SEC document |
| May 03, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,276 | $312.50 | $711,250.00 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · nonDerivative · entry 4 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,272 Read SEC document |
| May 02, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 2,919 | $70.30 Strike: $70.30 | $205,205.70 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · derivative · entry 6 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,600 Underlying: capital stock · 2,919 shares Expires 2023-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/8/2014. Read SEC document |
| May 02, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $106.59 Strike: $106.59 | $1,065,900.00 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · derivative · entry 5 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,519 Underlying: capital stock · 10,000 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/7/2015 Read SEC document |
| May 02, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,643 | $312.50 | $3,325,937.50 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · nonDerivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,548 Read SEC document |
| May 02, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $106.59 | $1,065,900.00 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · nonDerivative · entry 2 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2018 Filed May 4, 2018 16:31 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,919 | $70.30 | $205,205.70 |
DisclosureSEC source: 0001209191-18-027986 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · derivative · entry 6 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,320 Underlying: capital stock · 1,178 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. F7 · derivative.expiration_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · derivative · entry 5 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,142 Underlying: capital stock · 354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · derivative · entry 4 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,496 Underlying: capital stock · 354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 378 | $256.29 | $96,877.62 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · nonDerivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,272 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 722 | $256.29 | $185,041.38 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · nonDerivative · entry 2 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2015 through December 31, 2017, compared to a defined peer group of companies. The Company's performance ranked in the 90th percentile of that group, yielding an award of 200%; including the reinvestment of dividends paid during such period, the award is 203.9% of target. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 18:39 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 577 | $256.29 | $147,879.33 |
DisclosureSEC source: 0001209191-18-011189 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2015 through December 31, 2017. The actual performance of 11.79% yielded an award of 159.9% of target; including the reinvestment of dividends paid during such period, the award is 163.0% of target. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:01 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $157.36 Strike: $157.36 | $1,573,600.00 |
DisclosureSEC source: 0001209191-17-060544 · doc4.xml · derivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,519 Underlying: capital stock · 10,000 shares Expires 2020-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:01 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $231.00 | $2,310,000.00 |
DisclosureSEC source: 0001209191-17-060544 · doc4.xml · nonDerivative · entry 2 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,351 Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 18:01 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $157.36 | $1,573,600.00 |
DisclosureSEC source: 0001209191-17-060544 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 16:21 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 19,600 | $231.91 Strike: $231.91 | $4,545,436.00 |
DisclosureSEC source: 0001209191-17-059366 · doc4.xml · derivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,519 Underlying: capital stock · 19,600 shares Expires 2022-11-03 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| May 22, 2017 Filed May 22, 2017 19:34 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 160 | $198.86 | $31,817.60 |
DisclosureSEC source: 0001209191-17-034239 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,351 F1 · kind: stock award tax obligation Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 1,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · derivative · entry 7 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,850 Underlying: capital stock · 1,352 shares Expires not disclosed F7 · derivative.exercise_price: each performance stock unit represents a contingent right to receive one share of Chemed capital stock F8 · derivative.exercise_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2017 - December 31, 2019. The determination of the performance level is to be made by March 15, 2020 and earned shares to be delivered thereafter F8 · derivative.expiration_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2017 - December 31, 2019. The determination of the performance level is to be made by March 15, 2020 and earned shares to be delivered thereafter Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · derivative · entry 6 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,498 Underlying: capital stock · 355 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. F6 · derivative.expiration_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 201 | $172.60 | $34,692.60 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · nonDerivative · entry 4 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,511 F4 · kind: stock award tax obligation Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 414 | $172.60 | $71,456.40 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · nonDerivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,712 F3 · kind: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 726 | $172.60 | $125,307.60 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · nonDerivative · entry 2 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2014 through December 31, 2016, compared to a defined peer group of companies. The Company's performance ranked in the 91st percentile of that group, yielding an award of 200%; including the reinvestment of dividends paid during such period, the award is 204.6% of target. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 569 | $172.60 | $98,209.40 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2014 through December 31, 2016. The actual performance of 8.23% yielded an award of 115.4% of target; including the reinvestment of dividends paid during such period, the award is 118.0% of target. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 21:21 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 36,000 | $135.85 Strike: $135.85 | $4,890,600.00 |
DisclosureSEC source: 0001209191-16-148852 · doc4.xml · derivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,919 Underlying: capital stock · 36,000 shares Expires 2021-11-04 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| February 17, 2016 Filed Feb 21, 2017 14:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012482 · doc4.xml · derivative · entry 5 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853 Underlying: capital stock · 482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F6 · derivative.exercise_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. F6 · derivative.expiration_date: PSU's awarded November 7, 2014 vest based on achievement of performance targets over a period of January 1, 2014 to December 31, 2016. The determination of the performance level was to be made by March 15, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.